Tag: Ziyad Al-Aly

“The research on declining rates of long COVID marks the rare occasion when I have good news to report regarding this virus,” said senior author Ziyad Al-Aly, MD, assistant professor & Public Health Faculty Scholar, about new research published in the New England Journal of Medicine.

The risk of developing long COVID has significantly decreased since the start of the pandemic, according to a new study published in the New England Journal of Medicine & co-authored by Ziyad Al-Aly, MD, assistant professor & Public Health Faculty Scholar.

A new study published in the New England Journal of Medicine & co-authored by Ziyad Al-Aly, MD, assistant professor & Public Health Faculty Scholar, found that chances of developing long COVID have significantly dropped since the pandemic began due to vaccinations and changes in the virus.

The risk of acquiring long COVID has dropped since the start of the pandemic, primarily due to vaccination, although it is still a persistent threat, according to research published in the New England Journal of Medicine & co-authored by Ziyad Al-Aly, MD, assistant professor & Public Health Faculty Scholar.

“Covid is a serious threat to the long-term health and well-being of people and it should not be trivialized,” says Ziyad Al-Aly, MD, assistant professor and Public Health Faculty Scholar, in a Daily Mail article on long COVID.

“People are developing new-onset disease as the result of an infection that they had three years ago,” says said senior author Ziyad Al-Aly, MD, assistant professor and Public Health Faculty Scholar, regarding his research published in Nature Medicine, that tracked COVID-19’s health effects in people infected with the original strain in 2020.

“We aren’t sure why the virus’s effects linger for so long,” says senior author Ziyad Al-Aly, MD, assistant professor and Public Health Faculty Scholar, regarding his research published in Nature Medicine that tracked COVID-19’s health effects in people infected with the original virus strain in 2020.

Eric Topol, MD, director of the Scripps Research Translational Institute, recognized Ziyad Al-Aly, MD, assistant professor, and Public Health Faculty Scholar, among the TIME100 Health honorees who helped find COVID solutions during the pandemic, remarking that “his middle name is long COVID.”

Ziyad al-Aly, assistant professor, School of Medicine, and Public Health Faculty Scholar was a guest on The World podcast speaking about the ways patients experience long COVID and what treatments are available.

Ziyad Al-Aly, MD, assistant professor, and Public Health Faculty Scholar, has been chosen as one of the most influential people in health in 2024, for his research on the long-term effects of COVID-19, in Time Magazine’s TIME 100 HEALTH.

Ziyad Al-Aly, MD, Public Health Faculty Scholar and WashU epidemiologist, was recently quoted in a NYT article about Pemgarda, a new drug for immunocompromised people to lower their chance of becoming infected with COVID.

Ziyad Al-Aly, MD, assistant professor, School of Medicine, was recently quoted in a Today article about the long-term and mild to debilitating health issues associated with long COVID.

Ziyad Al-Aly, MD, Public Health Faculty Scholar and WashU epidemiologist, who has been researching long COVID before it was named “long COVID”, discusses a new study finding that COVID-19 infection affects memory and decision-making performance.

Ziyad Al-Aly, MD, Public Health Faculty Scholar and WashU epidemiologist weighs in on a recent study suggesting that when long Covid symptoms improve, associated cognitive impairment might also.

A study co-authored by Ziyad Al-Aly, MD, Public Health Faculty Scholar and WashU epidemiologist, found that patients hospitalized with influenza can also experience lingering problems similar to those found in patients with long COVID.

Ziyad Al-Aly, MD, Public Health Faculty Scholar and WashU epidemiologist, discusses recurring COVID infections and why long-term, sustainable solutions are needed.

“Long Covid in the U.S., in adults and in kids, is a serious problem,” says Ziyad Al-Aly, WashU epidemiologist and Public Health Faculty Scholar, in response to a recent published paper on the incidence of long Covid in children.

A study co-authored by Ziyad Al-Aly, MD, Public Health Faculty Scholar and WashU epidemiologist, found that patients hospitalized with influenza can also experience lingering problems similar to those found in patients with long COVID.

Ziyad Al-Aly, MD, Public Health Faculty Scholar and WashU epidemiologist, proposed a solution to Covid-related chronic conditions as he testified before the U.S. Senate Committee on Health, Education, Labor and Pensions.

Public Health Faculty Scholar and epidemiologist, Ziyad Al-Aly says that long COVID is now “on par with the burden of cancer and heart disease.”

Ziyad Al-Aly, public health faculty scholar and WashU epidemiologist testified at a hearing before the Senate Committee on Health, Education, Labor and Pensions on issues affecting patients suffering from long COVID.

Can recent and repeated COVID-19 vaccines help reduce the chances of long COVID? Ziyad Al-Aly, public health faculty scholar and WashU epidemiologist, talks about it.

New variant, flu, RSV…lots going on out there. Public Health Faculty Scholar and WashU Epidemiologist, Ziyad Al-Aly says we’ll likely see a rise of illness in January now that the holidays are over.

First long COVID, now long flu? According to a new study, lingering lung problems are just one of the problems some are experiencing 18 months after illness. Ziyad Al-Aly, MD talks about his research.

Epidemiologist and Public Health Faculty Scholar, Ziyad Al-Aly says there is no “empiric evidence that COVID can lead to cancer” but the possibility is also not yet ruled out.

Ziyad Al-Aly recently spoke with National Public Radio about the latest findings on how long COVID symptoms affect the brain.

Public Health Faculty Scholar and Asst. Professor at the School of Medicine, Ziyad Al-Aly weighs in on how long COVID disrupts the brain.

Epidemiologist and Faculty Scholar, Ziyad Al-Aly led a study showing a higher likelihood of death or hospitalization among COVID-19 patients who have been infected more than once vs. those infected only once.

Faculty Scholar and clinical epidemiologist, Ziyad Al-Aly talks about COVID-19 as a risk factor for heart disease.

Ziyad Al-Aly, faculty scholar and epidemiologist says news of COVID-19 rebounds may be “overblown”.

Ziyad Al Aly, epidemiologist and institute faculty scholar says that after a COVID diagnosis people who haven’t had cholesterol problems before, are now having problems.

Clinical epidemiologist and Faculty Scholar, Ziyad Al-Aly, MD, discusses immunity vs. health risks following COVID reinfection.

Faculty Scholar and clinical epidemiologist, Ziyad Al-Aly, MD, who studies long COVID, discusses mitigation efforts to stop the prolonged impact of the virus.

Clinical epidemiologist and Faculty Scholar, Ziyad Al-Aly has a different opinion of a new, large study finding that long Covid symptoms clear after a year.